2438 Results for "

decrease

" in MedChemExpress (MCE) Product Catalog:
Products (2438)

2438 Results for "decrease" in MCE Product Catalog:

Cat. No.: HY-113486R
CAS No.: 80-99-9
Lathosterol (Standard) is the analytical standard of Lathosterol (HY-113486). This product is intended for research and analytical applications. Lathosterol is a plant sterol and cholesterol-like molecule. Lathosterol increases antioxidant enzymes (such as SOD, CAT, and GSH) and decreases LDH. Lathosterol has a hepatoprotective effect on mice with acetaminophen (HY-66005)-induced liver injury [1] .
loading...
    loading...
Cat. No.: HY-114527
CAS No.: 102660-13-9
연구분야:  

Cancer

TPMP-I-2 is an anticancer agent that induces cancer cell lines Apoptosis and decreases protein levels of stearoyl-CoA desaturase. TPMP-I-2 prolongs the survival time of nude rats in a simulated micrometastatic cervical cancer model and reduces tumor growth in a breast cancer model in nude mice combined with immunotoxins .
loading...
    loading...
Cat. No.: HY-115877
CAS No.: 1984824-54-5
Target:  

TRP Channel

연구분야:  

Others

GDC-0334 is a selective TRPA1 antagonist. GDC-0334 inhibits TRPA1 function on airway smooth muscle and sensory neurons by decreasing cough and allergic airway inflammation in rats and guinea pigs. GDC-0334 can be used for TRPA1-mediated diseases research, such as pain or asthma .
loading...
    loading...
Cat. No.: HY-117075
CAS No.: 421592-30-5
Target:  

SGLT

연구분야:  

Metabolic Disease

BI-44847 is a selective and orally active SGLT2 inhibitor. BI-44847 can increase UGE and decrease HbA1c levels. BI-44847 shows improvement in fasting and fed glucose levels. BI-44847 can be studied in research on type 2 diabetes mellitus (T2DM) .
loading...
    loading...
Cat. No.: HY-119159
CAS No.: 361465-74-9
Target:  

NAMPT Caspase Apoptosis

연구분야:  

Cancer

AS1604498 is a highly specific competitive inhibitor of human NAMPT, with an IC50 of 44.4 nM. AS1604498 functionally inhibits NAMPT enzymatic activity, reduces nicotinamide mononucleotide production, decreases intracellular NAD levels, activates caspase 3/7 and induces cancer cell apoptosis. AS1604498 is applicable to research related to chronic myeloid leukemia .
loading...
    loading...
Cat. No.: HY-122464S2
CAS No.: 2750534-78-0
Purity:  ≥98.0%
(±)-Jasmonic acid-d5 is the deuterium labeled (±)-Jasmonic acid. (±)-Jasmonic acid is a plant growth regulator and a derivative of α-linolenic acid. (±)-Jasmonic acid decreases chlorophyll levels in green and etiolated barley leaf segments and inhibits elongation of rice seedlings.
The product specifications provided below refer solely to the active content of (±)-Jasmonic acid-d5.
loading...
    loading...
Cat. No.: HY-122753
CAS No.: 1643469-17-3
Purity:  99.83%
Target:  

MDM-2/p53

연구분야:  

Cancer

SLMP53-1 is a wild-type and mutant p53 reactivator with promising antitumor activity. SLMP53-1 mediates the reprograming of glucose metabolism in cancer cells. SLMP53-1 depletes angiogenesis, decreasing endothelial cell tube formation and vascular endothelial growth factor (VEGF) expression levels .
loading...
    loading...
Cat. No.: HY-12352
CAS No.: 1617518-22-5
Target:  

STAT Apoptosis

연구분야:  

Cancer

HJC0416 is a potent and orally active STAT3 inhibitor. HJC0416 shows antiprolifeative activity and induces Apoptosis. HJC0416 decreases the expression of p-STAT3 (Tyr-705), Cyclin D1 and increases the expression of cleaved caspase-3 protein. HJC0416 shows anti-tumor activity .
loading...
    loading...
Cat. No.: HY-127022A
CAS No.: 76822-34-9
Synonyms: Daturamine hydrobromide; α-Hydroxyscopolamine hydrobromide
Anisodine (Daturamine) hydrobromide is a neuroprotective compound that reduces exacerbated M1, M2, M4, and M5 receptor expression in brain tissues under hypoxia/reoxygenation conditions. Anisodine hydrobromide inhibits calcium ion influx and reactive oxygen species (ROS)levels. Anisodine hydrobromide leads to decreased aspartate levels during hypoxia .
loading...
    loading...
Cat. No.: HY-129297
CAS No.: 86879-39-2
Purity:  99.57%
CMPF can be found in trace constituent of urine and blood. CMPF is a biomarker of type 2 diabetes. CMPF can act on the β cell and induces impaired mitochondrial function. CMPF decreases glucose-induced ATP accumulation, and induces oxidative stress. CMPF reverses hepatic lipid accumulation and improves insulin sensitivity in obese mice .
loading...
    loading...
Cat. No.: HY-133556
CAS No.: 2415643-79-5
Target:  

AMPK

연구분야:  

Metabolic Disease

IQZ23 inhibits adipocyte differentiation via AMPK pathway activation. IQZ23 exerts a high efficacy in decreasing the triglyceride level (EC50=0.033 μM) in 3T3-L1 adipocytes. IQZ23 could be used for the research of obesity and related metabolic disorders .
loading...
    loading...
Cat. No.: HY-135374
CAS No.: 131275-93-9
(3R,5S)-Atorvastatin sodium is an impurity of Atorvastatin. Atorvastatin is an orally active HMG-CoA reductase inhibitor, has the ability to effectively decrease blood lipids. Atorvastatin inhibits human SV-SMC proliferation and invasion with IC50s of 0.39 μM and 2.39 μM, respectively .
loading...
    loading...
Cat. No.: HY-135902
CAS No.: 502139-01-7
Synonyms: NSC 377363
Target:  

DNA/RNA Synthesis

연구분야:  

Neurological Disease

Synucleozid (NSC 377363) is a potent inhibitor of the SNCA mRNA that encodes α-synuclein protein. Synucleozid selectively targets the α-synuclein mRNA 5′ UTR at the designed IRE site, decreases the amount of SNCA mRNA loaded into polysomes and thereby inhibits SNCA translation. Synucleozid has the potential for the investigation of Parkinson’s disease .
loading...
    loading...
Cat. No.: HY-137874
CAS No.: 1955-67-5
Purity:  99.56%
Target:  

Inhibitory Antibodies

연구분야:  

Metabolic Disease Cancer

L-Glutamic γ-monohydroxamate is an antitumor agent, inhibits cell proliferation. L-Glutamic γ-monohydroxamate selectively inhibits the uptake of L-histidine into microvascular endothelial cell. L-Glutamic γ-monohydroxamate, as a vanadium ligand, activates glucose uptake and metabolism, thus decreases the blood glucose levels in vivo .
loading...
    loading...
Cat. No.: HY-144289
CAS No.: 1001419-18-6
Purity:  99.75%
Target:  

Glucokinase

연구분야:  

Metabolic Disease

BMS-820132 is an orally active and partial glucokinase (GK) activator with a AC50 of 29 nM. BMS-820132 decreases the glucose levels in glucose tolerance test (OGTT) model in normal rats, but not Zucker diabetic fatty (ZDF) rats. BMS-820132 exhibits pharmacological toxicity secondary to strong GK activation .
loading...
    loading...
Cat. No.: HY-147770
Target:  

NF-κB

연구분야:  

Inflammation/Immunology

NF-κB-IN-6 (Compound 3d) is an anti-inflammatory agent through the mechanism of decreasing the protein expressions of iNOS and COX-2 by suppressing NF-κB signaling pathway. NF-κB-IN-6 inhibits NO production in LPS-induced RAW264.7 cells with an IC50 of 23.1 μM .
loading...
    loading...
Cat. No.: HY-147983
CAS No.: 2315320-24-0
연구분야:  

Cancer

PI3Kα-IN-8 (Compound 9g) is a selective PI3Kα inhibitor with an IC50 of 0.012 μM. PI3Kα-IN-8 increases intracellular reactive oxygen species level, decreases mitochondrial membrane potential and induces apoptosis .
loading...
    loading...
Cat. No.: HY-148189R
CAS No.: 2904601-67-6
Synonyms: LXY-05-029 (Standard)
Aldometanib (Standard) is the analytical standard of Aldometanib (HY-148189). This product is intended for research and analytical applications. Aldometanib (LXY-05-029) is an orally active aldolase inhibitor. Aldometanib can activate lysosomal adenosine monophosphate-activated protein Kinase (AMPK) and decreases blood glucose. Aldometanib can be used for the research of metabolic homeostasis .
loading...
    loading...
Cat. No.: HY-148698
CAS No.: 213250-70-5
Target:  

VD/VDR

연구분야:  

Others

2MD is an orally active vitamin D analog. 2MD stimulates periosteal bone formation and decreases trabecular bone resorption. Thus 2MD restores trabecular and cortical bone mass and strength. 2MD also regulates intraocular pressure (IOP)-relative genes and reduces IOP in non-human primates .
loading...
    loading...
Cat. No.: HY-149205
CAS No.: 2919976-92-2
Target:  

PI3K ERK

연구분야:  

Inflammation/Immunology

CXJ-2 is a cyclic peptide, and exhibits moderate affinity toward elastin derived peptides (EDPs). CXJ-2 exhibits potent activities to inhibit the PI3K/ERK pathway and decrease hepatic stellate cell proliferation and migration. CXJ-2 possesses potent antifibrotic efficacy .
loading...
    loading...